Simplexia - Crunchbase Company Profile & Funding

Overview

Simplexia

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

See more interactive data and historical milestones on desktop for the best experience

About Simplexia

CB Rank

681922

Simplexia uses a new strategy to develop a vaccine against herpes simplex virus type 2 (HSV-2) infection.

Private

simplexia.se/

Health Care

Information Technology

Details

Legal Name

Simplexia AB

Operating Status

Active

Company Type

For Profit

About the Company

Simplexia uses a new strategy to develop a vaccine against herpes simplex virus type 2 (HSV-2) infection.

Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

HSV-2 Vaccine Candidate mgG2 EXCT4

A protein subunit vaccine candidate targeting HSV-2 using a soluble recombinant variant of glycoprotein G-2 to prevent and treat genital herpes infection.

Research & Development

Simplexia is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...